Abstract 2053P
Background
In recent decades, the home care initiative has expanded in the health system, mainly linked to hospitals. The mismatch between available financial resources and advances related to cancer therapy requires projects to improve cost minimization processes.
Methods
The variables collected for each sector were described through monthly totals and averages per year. To verify the existence of an association between expenses with material, medication and chemotherapy and the cost avoided with monthly dehospitalization, Pearson's correlation coefficients and their respective p-values were calculated. Spending on medication and total spending on material, medication and chemotherapy were related to the amount avoided using linear regression models, in order to estimate the effect of increased spending on medication on avoided costs. The same procedure was performed to estimate the effect of increased costs on bed turnover, using linear regressions, and on the number of days of hospitalization avoided per month, using Poisson regression.
Results
Pearson's coefficients confirm a relationship, with a positive sign, between expenses and avoided costs with early dehospitalization, showing a perfect positive relationship between the variables, with a statistically significant p-value. Effect of expenses on total costs with hospitalization avoided on General Hospitalization, Coefficients - Amount spent on medication:100.36; 95% CI (14.26, 186.45); p-value= 0.02. By the linear model, the total avoided cost with discharges was $795,204.52 in the three-year period from 2020 to 2022, for a total of 3,722 avoided hospitalization days and an average cost avoided with discharges of $70,146.06. Effect of expenses on the days of hospitalization avoided (Poisson regression) was statistically significant in all variables (p-value<0.001).
Conclusions
All tests - Pearson Correlation coefficients, Poisson regression, and Generalized Linear Model (p<0.05) confirmed the hypothesis that the discharge managing with outpatient drug release has a significant effect on the final cost avoided with cancer hospitalization.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2096P - Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)
Presenter: Seok Jae Huh
Session: Poster session 06
2097P - Incidence, risk factors (RFs) and management of oral mucositis (OM) in patients (pts) treated with a fluoropyrimidines (FP)-based therapy (tp): A retrospective, monocentric experience
Presenter: Fiorella Manfredi
Session: Poster session 06
2098P - The impact of concomitant use of non-opioid analgesics and immune checkpoint inhibitors on survival in lung cancer patients: A Hong Kong population-based cohort study
Presenter: Zheng-Hao Ye
Session: Poster session 06
2099P - The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis
Presenter: Elina Khachaturian
Session: Poster session 06
2100P - An exploratory study of the efficacy and safety of hetrombopag in the treatment of thrombocytopenia induced by concurrent or sequential chemoradiotherapy
Presenter: Jun Wang
Session: Poster session 06
2101P - Bleeding Induced by ANtiCAncer drugs (BIANCA) used breast cancer
Presenter: Nicolas Janus
Session: Poster session 06
2102P - Changes in opioid usage after intrathecal morphine pump implantation in patients with terminal cancer (pilot study)
Presenter: Eun Joo Choi
Session: Poster session 06
2103P - Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer
Presenter: Daniel Osei-Fofie
Session: Poster session 06
2104P - Prevention of taxane chemotherapy induced nail changes and peripheral neuropathy by application of extremity cooling: A prospective single center study with intrapatient comparison
Presenter: Kristen Johnson
Session: Poster session 06
2105P - Prophylactic role of a postbiotic microbiota-stabilizer on abemaciclib-induced diarrhea in breast cancer patients: A pilot application study
Presenter: Rita De Sanctis
Session: Poster session 06